Spectral Medical (TSE:EDT) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Spectral Medical is pushing forward with its Tigris trial, enrolling 136 patients by the end of November despite supply chain disruptions caused by Hurricane Helene. The company expects to achieve full enrollment by the end of Q1 2025 and remains optimistic about overcoming these temporary setbacks.
For further insights into TSE:EDT stock, check out TipRanks’ Stock Analysis page.
